Ueda N et al. |
Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. |
2013 |
FEBS J. |
pmid:23425575
|
Bari M et al. |
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system. |
2013 |
FEBS J. |
pmid:23659592
|
van der Stelt M et al. |
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. |
2005 |
FASEB J. |
pmid:15894565
|
DiPatrizio NV et al. |
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. |
2013 |
FASEB J. |
pmid:23463697
|
Bátkai S et al. |
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. |
2007 |
FASEB J. |
pmid:17327359
|
Siegmund SV et al. |
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. |
2007 |
FASEB J. |
pmid:17440119
|
Karwad MA et al. |
The role of CB in intestinal permeability and inflammation. |
2017 |
FASEB J. |
pmid:28404744
|
Maestroni GJ |
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. |
2004 |
FASEB J. |
pmid:15385435
|
Tam J et al. |
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. |
2008 |
FASEB J. |
pmid:17704191
|
Baker D et al. |
Endocannabinoids control spasticity in a multiple sclerosis model. |
2001 |
FASEB J. |
pmid:11156943
|
Alhouayek M et al. |
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. |
2011 |
FASEB J. |
pmid:21551239
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Alhouayek M et al. |
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis. |
2015 |
FASEB J. |
pmid:25384424
|
Di Marzo V et al. |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. |
2000 |
FASEB J. |
pmid:10877836
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|
Granchi C et al. |
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017). |
2017 |
Expert Opin Ther Pat |
pmid:29053063
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Zheng G et al. |
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways. |
2015 |
Exp. Neurol. |
pmid:26408049
|
Mounsey RB et al. |
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. |
2015 |
Exp. Neurol. |
pmid:26244281
|
Köse S et al. |
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation. |
2018 |
Exp. Hematol. |
pmid:29030083
|
Pascual AC et al. |
Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging. |
2014 |
Exp. Gerontol. |
pmid:24768821
|
Njie YF et al. |
Aqueous humor outflow effects of 2-arachidonylglycerol. |
2008 |
Exp. Eye Res. |
pmid:18597752
|
Jumpertz R et al. |
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide. |
2010 |
Exp. Clin. Endocrinol. Diabetes |
pmid:20429051
|
Frampton G et al. |
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. |
2010 |
Exp. Cell Res. |
pmid:20347808
|
Evagorou A et al. |
Hydrolysis of 2-arachidonoylglycerol in Tetrahymena thermophila. Identification and partial characterization of a Monoacylglycerol Lipase-like enzyme. |
2010 |
Eur. J. Protistol. |
pmid:20889319
|
Petrenko AB et al. |
Genetic inactivation and prolonged pharmacologic inhibition of monoacylglycerol lipase have opposite effects on anesthetic sensitivity to propofol. |
2015 |
Eur. J. Pharmacol. |
pmid:26318148
|
Fride E et al. |
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. |
2003 |
Eur. J. Pharmacol. |
pmid:12568912
|
Wiley JL et al. |
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. |
2014 |
Eur. J. Pharmacol. |
pmid:24858366
|
Gallily R et al. |
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. |
2000 |
Eur. J. Pharmacol. |
pmid:11011050
|
Kojima S et al. |
Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro. |
2002 |
Eur. J. Pharmacol. |
pmid:12063081
|
Shimizu T and Yokotani K |
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats. |
2008 |
Eur. J. Pharmacol. |
pmid:18234185
|
Smid SD et al. |
The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon. |
2007 |
Eur. J. Pharmacol. |
pmid:17706636
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Shimizu T et al. |
Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats. |
2011 |
Eur. J. Pharmacol. |
pmid:21371452
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Hill MN et al. |
Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. |
2005 |
Eur. J. Pharmacol. |
pmid:16324692
|
Deshpande LS et al. |
Endocannabinoids block status epilepticus in cultured hippocampal neurons. |
2007 |
Eur. J. Pharmacol. |
pmid:17174949
|
Mukherjee S et al. |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15556131
|
Kagota S et al. |
2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. |
2001 |
Eur. J. Pharmacol. |
pmid:11275004
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
Ben-Shabat S et al. |
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. |
1998 |
Eur. J. Pharmacol. |
pmid:9721036
|
Oka S et al. |
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol. |
2006 |
Eur. J. Pharmacol. |
pmid:16647054
|
Mechoulam R et al. |
Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. |
1998 |
Eur. J. Pharmacol. |
pmid:9865537
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Thors L and Fowler CJ |
Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids. |
2009 |
Eur. J. Pharmacol. |
pmid:19715690
|
Nabemoto M et al. |
Release of arachidonic acid by 2-arachidonoyl glycerol and HU210 in PC12 cells; roles of Src, phospholipase C and cytosolic phospholipase A(2)alpha. |
2008 |
Eur. J. Pharmacol. |
pmid:18539271
|
Shimizu T et al. |
Possible inhibitory roles of endogenous 2-arachidonoylglycerol during corticotropin-releasing factor-induced activation of central sympatho-adrenomedullary outflow in anesthetized rats. |
2010 |
Eur. J. Pharmacol. |
pmid:20519139
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Kortleven C et al. |
The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. |
2011 |
Eur. J. Neurosci. |
pmid:21410793
|